Companies › ABBV
ABBVIE INC (ABBV)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001551152 · EDGAR filings · Updated 2026-07-06
ABBVIE INC (ABBV) has reported institutional ownership of 73.5%, with 4,042 institutional managers holding positions valued at $281.4B per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06). The company has 33 bond series in the registry.
Latest updates
- 2026-07-06 — Current report (8-K) filed
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-06-24 — 11-K filed
- 2026-06-22 — Current report (8-K) filed
- 2026-06-01 — SD filed
- 2026-05-26 — Notice of proposed sale filed (Form 144)
- 2026-05-12 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ABBVIE INC has 4,042 institutional holders and institutional ownership of 73.5%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $32.8B | 11.6% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $25.0B | 8.9% |
| 3 | STATE STREET CORP | $17.7B | 6.3% |
| 4 | JPMORGAN CHASE & CO | $12.1B | 4.3% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | $10.8B | 3.8% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $10.1B | 3.6% |
| 7 | MORGAN STANLEY | $8.27B | 2.9% |
| 8 | Capital Research Global Investors | $6.80B | 2.4% |
| 9 | BANK OF AMERICA CORP /DE/ | $5.21B | 1.8% |
| 10 | FMR LLC | $4.73B | 1.7% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 73 transactions (0 buys, 10 sells) across 24 reporting insiders, with a net reported value of −$34.2M.
Quarterly net insider value, as reported in Form 4 filings.
Data flags from SEC filings
Debt profile
33 active bond series in the registry, coupons ranging 2.95%–5.65%, maturities through 2066, built from the company's own prospectus filings.
Debt maturity schedule
Principal coming due by year for ABBVIE INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2026 | 2 | $4.00B |
| 2027 | 2 | $3.08B |
| 2028 | 10 | $4.50B |
| 2029 | 2 | $7.75B |
| 2030 | 2 | $1.00B |
| 2031 | 3 | $3.25B |
| 2033 | 1 | — |
| 2034 | 1 | $3.00B |
| 2035 | 4 | — |
| 2036 | 2 | — |
| 2039 | 1 | — |
| 2042 | 3 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Related companies
ELI LILLY AND CO (LLY) · JOHNSON & JOHNSON (JNJ) · MERCK & CO. INC. (MRK) · AMGEN INC (AMGN) · ASTRAZENECA PLC (AZN) · GILEAD SCIENCES INC (GILD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.